These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35992895)

  • 1. Mitochondria-lysosome crosstalk in GBA1-associated Parkinson's disease.
    Sahyadri M; Nadiga APR; Mehdi S; Mruthunjaya K; Nayak PG; Parihar VK; Manjula SN
    3 Biotech; 2022 Sep; 12(9):230. PubMed ID: 35992895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of Parkinson's disease.
    Kim S; Wong YC; Gao F; Krainc D
    Nat Commun; 2021 Mar; 12(1):1807. PubMed ID: 33753743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between glucocerebrosidase mutations and Parkinson disease.
    Migdalska-Richards A; Schapira AH
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):77-90. PubMed ID: 26860875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells.
    Ambrosi G; Ghezzi C; Zangaglia R; Levandis G; Pacchetti C; Blandini F
    Neurobiol Dis; 2015 Oct; 82():235-242. PubMed ID: 26094596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N370S-GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson's disease.
    García-Sanz P; Orgaz L; Bueno-Gil G; Espadas I; Rodríguez-Traver E; Kulisevsky J; Gutierrez A; Dávila JC; González-Polo RA; Fuentes JM; Mir P; Vicario C; Moratalla R
    Mov Disord; 2017 Oct; 32(10):1409-1422. PubMed ID: 28779532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosome and Inflammatory Defects in GBA1-Mutant Astrocytes Are Normalized by LRRK2 Inhibition.
    Sanyal A; DeAndrade MP; Novis HS; Lin S; Chang J; Lengacher N; Tomlinson JJ; Tansey MG; LaVoie MJ
    Mov Disord; 2020 May; 35(5):760-773. PubMed ID: 32034799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.
    Ortega RA; Torres PA; Swan M; Nichols W; Boschung S; Raymond D; Barrett MJ; Johannes BA; Severt L; Shanker V; Hunt AL; Bressman S; Pastores GM; Saunders-Pullman R
    J Clin Neurosci; 2016 Jun; 28():185-6. PubMed ID: 26857292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson's disease.
    Burbulla LF; Jeon S; Zheng J; Song P; Silverman RB; Krainc D
    Sci Transl Med; 2019 Oct; 11(514):. PubMed ID: 31619543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-lysosome contact site dynamics and misregulation in neurodegenerative diseases.
    Cisneros J; Belton TB; Shum GC; Molakal CG; Wong YC
    Trends Neurosci; 2022 Apr; 45(4):312-322. PubMed ID: 35249745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-hit in vivo model of GBA viral microRNA-mediated downregulation and human alpha-synuclein overexpression demonstrates nigrostriatal degeneration.
    Polissidis A; Koronaiou E; Nikolopoulou G; Viel C; Nikatou M; Bogiongko M; Sardi SP; Xilouri M; Vekrellis K; Stefanis L
    Neurobiol Dis; 2022 Feb; 163():105612. PubMed ID: 34995756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease.
    Horowitz M; Braunstein H; Zimran A; Revel-Vilk S; Goker-Alpan O
    Adv Drug Deliv Rev; 2022 Aug; 187():114402. PubMed ID: 35764179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between Lysosomes and Mitochondria in Parkinson's Disease.
    Plotegher N; Duchen MR
    Front Cell Dev Biol; 2017; 5():110. PubMed ID: 29312935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk of organelles in Parkinson's disease - MiT family transcription factors as central players in signaling pathways connecting mitochondria and lysosomes.
    Lang M; Pramstaller PP; Pichler I
    Mol Neurodegener; 2022 Jul; 17(1):50. PubMed ID: 35842725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblasts from idiopathic Parkinson's disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2.
    Thomas R; Moloney EB; Macbain ZK; Hallett PJ; Isacson O
    Mol Brain; 2021 Jan; 14(1):16. PubMed ID: 33468204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
    Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
    J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease.
    Magalhaes J; Gegg ME; Migdalska-Richards A; Doherty MK; Whitfield PD; Schapira AH
    Hum Mol Genet; 2016 Aug; 25(16):3432-3445. PubMed ID: 27378698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal Pathogenesis of Parkinson's Disease: Insights From LRRK2 and GBA1 Rodent Models.
    Volta M
    Neurotherapeutics; 2023 Jan; 20(1):127-139. PubMed ID: 36085537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of autophagic-lysosomal dysfunction in Gaucher disease and Parkinson's disease.
    Kinghorn KJ; Asghari AM; Castillo-Quan JI
    Neural Regen Res; 2017 Mar; 12(3):380-384. PubMed ID: 28469644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation and Function of Mitochondria-Lysosome Membrane Contact Sites in Cellular Homeostasis.
    Wong YC; Kim S; Peng W; Krainc D
    Trends Cell Biol; 2019 Jun; 29(6):500-513. PubMed ID: 30898429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model of GBA1-associated Parkinson's disease.
    Kumar M; Srikanth MP; Deleidi M; Hallett PJ; Isacson O; Feldman RA
    Hum Mol Genet; 2023 May; 32(11):1888-1900. PubMed ID: 36752535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.